These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials. Taghian AG, Jeong JH, Mamounas EP, Parda DS, Deutsch M, Costantino JP, Wolmark N. J Clin Oncol; 2006 Aug 20; 24(24):3927-32. PubMed ID: 16921044 [Abstract] [Full Text] [Related]
11. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL, Bellon JR, Wong JS, Smith BL, Harris JR. J Clin Oncol; 2008 May 10; 26(14):2373-8. PubMed ID: 18413639 [Abstract] [Full Text] [Related]
16. Prognostic markers of local relapse in rectal cancer: are we any further forward? Johnston PG. J Clin Oncol; 2006 Sep 01; 24(25):4049-50. PubMed ID: 16943520 [No Abstract] [Full Text] [Related]
19. Radiotherapy after segmental resection of breast cancer with favorable prognostic features: 12-year follow-up results of a randomized trial. Holli K, Hietanen P, Saaristo R, Huhtala H, Hakama M, Joensuu H. J Clin Oncol; 2009 Feb 20; 27(6):927-32. PubMed ID: 19114687 [Abstract] [Full Text] [Related]
20. Comprehensive locoregional treatment and systemic therapy for postmastectomy isolated locoregional recurrence. Kuo SH, Huang CS, Kuo WH, Cheng AL, Chang KJ, Chia-Hsien Cheng J. Int J Radiat Oncol Biol Phys; 2008 Dec 01; 72(5):1456-64. PubMed ID: 18692329 [Abstract] [Full Text] [Related] Page: [Next] [New Search]